Retatrutide Vial Septum Specs: The Fields Listings Name

A retatrutide vial septum material specification typically lists five things: the elastomer family the stopper is molded from, whether the solution-contact face carries a fluoropolymer laminate or a coating, whether the stopper is siliconized, the sterilization state it shipped in, and the closure standard the supplier tested it against. It describes the rubber, not the peptide. Purity, fill weight and concentration belong to the label and the certificate of analysis; the septum line only tells you what the needle passes through and what that material can shed into solution.

Which fields does a septum material specification list?

Most listings collapse the closure into two words. A specification that is actually usable separates the material from the marketing, field by field.

Field	A usable entry reads	A vague entry reads
Elastomer family	“bromobutyl” or “chlorobutyl,” named outright	“pharmaceutical-grade rubber”
Contact face	“PTFE-laminated face” or “uncoated butyl”	“non-reactive”
Silicone treatment	“siliconized” or “silicone-free”	field absent
Sterilization state	“gamma-irradiated, ready to use” or “washed only, not sterilized”	“sterile” with no method
Closure format	stopper diameter plus whether it is a lyophilization (slotted) stopper	“standard stopper”
Closure standard	the monograph named with its revision	“meets pharmacopoeial requirements”
Lot traceability	closure lot recorded separately from the peptide lot	field absent

Caption: septum specification fields and the wording that makes each one verifiable versus unverifiable. Field conventions only; no numeric claim is made in this table.

The field that carries the most weight is the contact face, because it governs what the solution touches for the whole time the vial sits reconstituted. An uncoated butyl stopper puts the peptide against cured rubber and whatever cure system that rubber uses; a laminated face puts a fluoropolymer film in between. A listing that names the elastomer but stays silent on lamination has told you the cheaper half of the answer.

Sterilization state is the field most often written to sound complete while saying nothing. “Sterile” describes a result; “gamma-irradiated, ready to use” describes a process someone can ask for records of. Treat the first as an unanswered question.

How many times does one vial’s septum get punctured?

Weekly subcutaneous administration is the cadence the retatrutide trial program runs on: the phase 2 obesity trial reported in the New England Journal of Medicine randomized 338 adults to once-weekly subcutaneous retatrutide at 1 mg, 4 mg, 8 mg or 12 mg or placebo for 48 weeks, and the TRIUMPH phase 3 program design paper keeps weekly subcutaneous dosing across four trials in over 5800 participants.

The route is the same one step back in the program: a phase 2 trial in type 2 diabetes randomized 281 participants to once-weekly subcutaneous injections between May 13, 2021 and June 13, 2022. Weekly withdrawal is the duty cycle a multi-dose septum has to survive, and it is arithmetic, not a property of the rubber.

Entries per vial = floor(vial mg ÷ withdrawal mg) + 1 for the diluent injection at reconstitution.

Vial (mg)	Withdrawal (mg)	Withdrawals per vial	Diluent entry	Total septum entries	Unused remainder (mg)
10	1	10	1	11	0
10	4	2	1	3	2
10	8	1	1	2	2
20	1	20	1	21	0
20	4	5	1	6	0
20	8	2	1	3	4
20	12	1	1	2	8

Caption: septum entries per vial, computed with the formula above. Vial sizes are the 10 mg and 20 mg lyophilized formats in the HEEZ catalog as of September 2026; withdrawal sizes are the once-weekly dose arms of the phase 2 obesity trial cited above. These figures describe container duty cycle for research-use material, not a dosing schedule.

Run it across the 48-week trial duration at a 4 mg withdrawal size and the vial format changes the load in two directions at once. With 10 mg vials: 48 withdrawals ÷ 2 per vial = 24 vials, at 3 entries each = 72 punctures spread across 24 septa. With 20 mg vials: 48 ÷ 5 = 9.6, so 10 vials, at 6 entries each = 60 punctures spread across 10 septa. The larger format cuts total punctures by 12 but doubles what any single septum absorbs, which is why a coring or resealing figure on a 20 mg listing carries more weight than the same figure on a 10 mg one.

The withdrawal-count column assumes the stated vial mass is what you can actually draw. It is not, quite: fill tolerance and residual volume both eat into it, and the diluent volume a 10 mg vial takes sets the concentration every row above is drawn at.

What does a PTFE-faced or coated septum change?

A laminated face is a thin fluoropolymer film bonded to the side of the stopper that meets the solution. Its job is to keep the elastomer’s cure residues, fillers and any absorbed moisture out of the liquid, and to stop the liquid’s components from sorbing into the rubber in the other direction. The rubber underneath still does the sealing; the film does the isolating.

That split matters for a lyophilized peptide because the film covers the top surface but not the puncture track. Once a needle has been through, the track exposes bare elastomer regardless of the laminate, which is the practical reason entries per septum belong in the same conversation as the material name.

Siliconization is the other entry that changes handling rather than chemistry. Silicone eases stopper insertion and machine handling and shows up as particulate in solution; a specification that states “silicone-free” is making a claim someone can test for, while silence on the field leaves it unresolved.

Septum spec vs. glass and seal specs: which tells you what?

The septum is one third of a closure system, and reading it alone produces confident wrong answers. Container chemistry lives in the glass field, where the glass type a listing names determines what the peptide solution contacts on the container side rather than the closure side.

Seal integrity lives in the crimp. The aluminum cap holds compression on the stopper, and it is also the field most often misread as a quality signal when cap color conventions are supplier inventory codes. A listing that specifies the elastomer precisely and leaves the seal type blank has documented the material and skipped the thing that keeps it sealed.

What to ask when a listing omits the septum line

1. Ask for the closure’s manufacturer and part number rather than a material adjective. A part number resolves to a published data sheet; “butyl” resolves to nothing.
2. Ask whether the stoppers arrived sterilized and ready to use or washed only, and by which method.
3. Ask whether the closure lot is recorded on the batch record next to the peptide lot, which is what makes a closure-related deviation traceable after the fact.
4. Ask whether the contact face is laminated and with which film.

If the first answer is a real part number, the remaining three are usually answerable from the closure manufacturer’s published data sheet without the supplier’s involvement at all.